VX-984 is a Selective Inhibitor of Non-homologous End Joining, with Possible Preferential Activity in Transformed Cells

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 Jun 15

PMID 29899825

Citations 16

Authors

Atif J Khan

Sarah M Misenko

Aditya Thandoni

Devora Schiff

Sachin R Jhawar

Samuel F Bunting

Bruce G Haffty

Affiliations

Soon will be listed here.

Abstract

Purpose: DNA double-strand breaks (DSBs) can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR). We demonstrate the selectivity of VX-984, a DNA-PK inhibitor, using assays not previously reported.

Experimental Design: The class switch recombination assay (CSR) in primary B cells was used to measure efficiency of NHEJ. A cellular reporter assay (U2OS EJ-DR) was used to assess the efficiency of HR and NHEJ in cells treated with VX-984. Immunofluorescence assays (IF) evaluated γ-H2AX foci for DSB repair kinetics in human astrocytes and T98G glioma cells. Western blotting was used to evaluate phosphorylation of DNA-PKcs substrates.

Results: We found a dose-dependent reduction in CSR efficiency with VX-984, and through the EJ-DR assay, dramatic dose-dependent increases in HR and mNHEJ. Immunofluorescence assays showed an inability of malignant cells to resolve γ-H2AX foci in the presence of VX-984. Radiation-induced phosphorylation of DNA-PK substrates was further reduced by treatment with VX-984.

Conclusions: VX-984 efficiently inhibits NHEJ, resulting in compensatory increases in alternative repair pathways, increases DSBs, and appears to affect transformed cells preferentially.

Citing Articles

DNA-PKcs suppresses illegitimate chromosome rearrangements.

Wang J, Sadeghi C, Frock R Nucleic Acids Res. 2024; 52(9):5048-5066.

PMID: 38412274 PMC: 11109964. DOI: 10.1093/nar/gkae140.

High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition.

Selvaraj S, Feist W, Viel S, Vaidyanathan S, Dudek A, Gastou M Nat Biotechnol. 2023; 42(5):731-744.

PMID: 37537500 DOI: 10.1038/s41587-023-01888-4.

Deuterium in drug discovery: progress, opportunities and challenges.

Di Martino R, Maxwell B, Pirali T Nat Rev Drug Discov. 2023; 22(7):562-584.

PMID: 37277503 PMC: 10241557. DOI: 10.1038/s41573-023-00703-8.

Deuterodehalogenation Under Net Reductive or Redox-Neutral Conditions Enabled by Paired Electrolysis.

Wood D, Lin S Angew Chem Int Ed Engl. 2023; 62(15):e202218858.

PMID: 36738472 PMC: 10050105. DOI: 10.1002/anie.202218858.

Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.

Chan Wah Hak C, Rullan A, Patin E, Pedersen M, Melcher A, Harrington K Front Oncol. 2022; 12:971959.

PMID: 36106115 PMC: 9465159. DOI: 10.3389/fonc.2022.971959.

References

Goodwin J, Knudsen K . Beyond DNA repair: DNA-PK function in cancer. Cancer Discov. 2014; 4(10):1126-39. PMC: 4184981. DOI: 10.1158/2159-8290.CD-14-0358. View

Bindra R, Goglia A, Jasin M, Powell S . Development of an assay to measure mutagenic non-homologous end-joining repair activity in mammalian cells. Nucleic Acids Res. 2013; 41(11):e115. PMC: 3675474. DOI: 10.1093/nar/gkt255. View

Davidson D, Grenier J, Martinez-Marignac V, Amrein L, Shawi M, Tokars M . Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells. Invest New Drugs. 2011; 30(4):1736-42. DOI: 10.1007/s10637-011-9678-5. View

Davidson D, Amrein L, Panasci L, Aloyz R . Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond. Front Pharmacol. 2013; 4:5. PMC: 3560216. DOI: 10.3389/fphar.2013.00005. View

Rizvi N, Hellmann M, Snyder A, Kvistborg P, Makarov V, Havel J . Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015; 348(6230):124-8. PMC: 4993154. DOI: 10.1126/science.aaa1348. View

Helleday T, Petermann E, Lundin C, Hodgson B, Sharma R . DNA repair pathways as targets for cancer therapy. Nat Rev Cancer. 2008; 8(3):193-204. DOI: 10.1038/nrc2342. View

Radhakrishnan S, Jette N, Lees-Miller S . Non-homologous end joining: emerging themes and unanswered questions. DNA Repair (Amst). 2014; 17:2-8. PMC: 4084493. DOI: 10.1016/j.dnarep.2014.01.009. View

Hill R, Lee P . The DNA-dependent protein kinase (DNA-PK): More than just a case of making ends meet?. Cell Cycle. 2010; 9(17):3460-9. DOI: 10.4161/cc.9.17.13043. View

Cui X, Yu Y, Gupta S, Cho Y, Lees-Miller S, Meek K . Autophosphorylation of DNA-dependent protein kinase regulates DNA end processing and may also alter double-strand break repair pathway choice. Mol Cell Biol. 2005; 25(24):10842-52. PMC: 1316975. DOI: 10.1128/MCB.25.24.10842-10852.2005. View

10.

Yannone S, Khan I, Zhou R, Zhou T, Valerie K, Povirk L . Coordinate 5' and 3' endonucleolytic trimming of terminally blocked blunt DNA double-strand break ends by Artemis nuclease and DNA-dependent protein kinase. Nucleic Acids Res. 2008; 36(10):3354-65. PMC: 2425473. DOI: 10.1093/nar/gkn205. View

11.

Hsu H, Yannone S, Chen D . Defining interactions between DNA-PK and ligase IV/XRCC4. DNA Repair (Amst). 2003; 1(3):225-35. DOI: 10.1016/s1568-7864(01)00018-0. View

12.

Dobbs T, Tainer J, Lees-Miller S . A structural model for regulation of NHEJ by DNA-PKcs autophosphorylation. DNA Repair (Amst). 2010; 9(12):1307-14. PMC: 3045832. DOI: 10.1016/j.dnarep.2010.09.019. View

13.

Sedelnikova O, Rogakou E, Panyutin I, Bonner W . Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res. 2002; 158(4):486-92. DOI: 10.1667/0033-7587(2002)158[0486:qdoiid]2.0.co;2. View

14.

Davis A, So S, Chen D . Dynamics of the PI3K-like protein kinase members ATM and DNA-PKcs at DNA double strand breaks. Cell Cycle. 2010; 9(13):2529-36. PMC: 3040849. DOI: 10.4161/cc.9.13.12148. View

15.

Takahashi A, Ohnishi T . Does gammaH2AX foci formation depend on the presence of DNA double strand breaks?. Cancer Lett. 2005; 229(2):171-9. DOI: 10.1016/j.canlet.2005.07.016. View

16.

Chen B, Chan D, Kobayashi J, Burma S, Asaithamby A, Morotomi-Yano K . Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J Biol Chem. 2005; 280(15):14709-15. DOI: 10.1074/jbc.M408827200. View

17.

Fillingham J, Keogh M, Krogan N . GammaH2AX and its role in DNA double-strand break repair. Biochem Cell Biol. 2006; 84(4):568-77. DOI: 10.1139/o06-072. View

18.

Rogakou E, Pilch D, Orr A, Ivanova V, Bonner W . DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998; 273(10):5858-68. DOI: 10.1074/jbc.273.10.5858. View

19.

Yannone S, Roy S, Chan D, Murphy M, Huang S, Campisi J . Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J Biol Chem. 2001; 276(41):38242-8. DOI: 10.1074/jbc.M101913200. View

20.

Manis J, Dudley D, Kaylor L, Alt F . IgH class switch recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity. 2002; 16(4):607-17. DOI: 10.1016/s1074-7613(02)00306-0. View